Topic: Muscle Loss

Singer Macy Gray was reportedly hospitalized due to side effects from Ozempic, highlighting the risks of GLP-1 drugs for weight loss. Author Johan Hari is cited regarding the "time bomb" of muscle mass loss and sarcopenia in older users. The segment also mentions "Triple G," a new generation of weight-loss drugs that target three different gut hormones for even more rapid weight reduction.

Major food corporations like Nestle and Abbott are developing "companion products" specifically for consumers taking GLP-1 weight loss medications. These products, such as protein shakes and fiber blends, aim to address side effects like muscle mass loss and "Ozempic ass." Startups are also entering the market with prebiotic supplements marketed as "nature's Ozempic" to mimic the drug's effects through natural means.

Scientific studies on Ozempic (semaglutide) indicate that a significant portion of the weight loss—up to 75% in some cases—comes from lean body mass rather than fat. This loss of muscle tissue is particularly concerning for older users who may struggle to regain it. The drug has become a cultural phenomenon in Hollywood, with celebrities like Chelsea Handler discussing its effects and the resulting "Ozempic face" caused by rapid facial fat loss.